(Q33934442)

30 July 2017

Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1 (English)

1 reference

30 July 2017

1 reference

1 reference

1 reference

5

Birke Bartosch

0 references

Jens Bukh

object named as

Jens Bukh

10

0 references

Harvey J. Alter

6

object named as

Harvey Alter

1 reference

30 July 2017

7

Suzanne U Emerson

1 reference

30 July 2017

9

Robert H Purcell

1 reference

30 July 2017

2

Ronald E Engle

1 reference

30 July 2017

8

Francois-Loic Cosset

1 reference

30 July 2017

Jean-Christophe Meunier

1

1 reference

30 July 2017

Kristina Faulk

3

1 reference

30 July 2017

Ming Zhao

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

14 March 2005

1 reference

Proceedings of the National Academy of Sciences of the United States of America

30 July 2017

1 reference

30 July 2017

102

1 reference

30 July 2017

12

1 reference

30 July 2017

4560-4565

1 reference

High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

Neutralizing antibody response during acute and chronic hepatitis C virus infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

HDL: the metabolism, function, and therapeutic importance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

Role of complement in the pathogenesis of SIV infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

Biogenesis of hepatitis C virus envelope glycoproteins

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

Antibody-mediated enhancement of viral disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

Experimental transmission of hepatitis C virus-associated fulminant hepatitis to a chimpanzee

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

Experimental infection of chimpanzees with hepatitis C virus of genotype 5a: genetic analysis of the virus and generation of a standardized challenge pool

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

Patients infected with the same hepatitis C virus strain display different kinetics of the isolate-specific antibody response.

5 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0501275102

Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0501275102

Non-A, non-B hepatitis in chimpanzees and marmosets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0501275102

Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0501275102

Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0501275102

Significance of the anti-E2 response in self-limited and chronic hepatitis C virus infections in chimpanzees and in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0501275102

Viral escape and the failure of cellular immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0501275102

Cross-reactivity and clinical impact of the antibody response to hepatitis C virus second envelope glycoprotein (E2).

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555507

High density lipoprotein receptors, binding proteins, and ligands

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15767578

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1073/PNAS.0501275102

1 reference

30 July 2017

0 references

1 reference

30 July 2017

1 reference